Albena Patroneva, M.D., MBA, Senior Vice President, Clinical Development
Dr. Patroneva, M.D., is a highly accomplished neurologist and epileptologist with over 25 years of industry experience in Neuroscience Drug Development and Medical Affairs. Prior to joining Neurogene, Dr. Patroneva worked as Chief Medical Officer at Marinus Pharmaceuticals, overseeing Clinical Development, Regulatory Affairs, Clinical Operations, and Patient Safety for multiple neurology and orphan diseases. Dr. Patroneva also served as Vice-President of the Clinical Development and Medical Affairs departments at Harmony Biosciences, where she established and initiated start-up activities for four neurology orphan indications. Prior to that, Dr. Patroneva served as Vice-President of Global Medical Affairs and Global Head of Multiple Sclerosis and Neurodegenerative Disorders at TEVA Pharmaceuticals, and has held other roles in CNS drug development, leading the full spectrum of clinical development activities from first-in-human trials through product launch and life cycle management. Dr. Patroneva received her medical degree at the Medical Academy of Sofia, Bulgaria. She holds board certification in neurology and early work in academia, including serving as Head of the EEG Lab at the Military Medical Academy of Sofia, Bulgaria, and as Assistant Professor of Neurophysiology at the Alexandrov Medical Hospital in Sofia. Dr. Patroneva also has an MBA in Health Management from Assen Zlatarov University in Burgas, Bulgaria.